糖尿病酮症酸中毒初始补液钾浓度与住院死亡率的关系
该回顾性队列研究利用日本诊断程序组合数据库,纳入2010年7月至2018年3月因糖尿病酮症酸中毒住院且无肾功能不全或血钾异常的患者,评估住院前2天输注液总钾浓度与28天住院死亡率的关系。结果显示钾浓度约10至40 mmol/L范围内与高钾血症或死亡无关,而更低浓度与更高死亡率相关,8 mmol/L组的比值比为1.69(95%CI 1.03-2.78,参照20 mmol/L)。
要点
- 钾浓度10至40 mmol/L范围内住院死亡率相似。
- 低于10 mmol/L的钾浓度与28天住院死亡率升高相关。
- 钾浓度约10至40 mmol/L内未增加高钾血症风险。
核心结论
- 输注钾浓度10至40 mmol/L的患者住院死亡率相似,更低浓度与更高死亡率相关。
主要发现
- 钾浓度四分位切点为7.7、11.4和16.1 mmol/L。
- 约10至40 mmol/L范围内,钾浓度与高钾血症发生或死亡无关。
- 较低钾浓度与更高28天住院死亡率相关,8 mmol/L组比值比1.69(95%CI 1.03-2.78,参照20 mmol/L),随浓度进一步降低比值比单调增加。
关键数值与推荐
- 全球指南推荐糖尿病酮症酸中毒初始补液钾替代浓度为10至40 mmol/L。
- 8 mmol/L组28天住院死亡比值比1.69(95%CI 1.03-2.78,参照20 mmol/L)。
临床怎么用
- 对糖尿病酮症酸中毒患者,初始补液钾浓度维持在10至40 mmol/L范围内与较低死亡率相关,应避免使用低于10 mmol/L的浓度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Guidelines worldwide recommend potassium replacement of 10 to 40 mmol/L in the initial fluid therapy for patients with diabetic ketoacidosis. However, evidence is lacking as to the association between infused potassium concentration and mortality. OBJECTIVE: We aimed to determine the association between infused potassium concentration and in-hospital mortality. METHODS: Using the Japanese Diagnosis Procedure Combination database, we retrospectively identified inpatients admitted for treatment of diabetic ketoacidosis from July 2010 to March 2018. Patients with kidney dysfunction or serum potassium abnormalities were excluded. We evaluated the association of the potassium concentration in the total infused solutions in the first 2 days of hospitalization with 28-day in-hospital mortality using multivariable regression analysis with a cubic spline model. We also assessed the association between potassium concentration and occurrence of hyperkalemia. RESULTS: We identified 14 216 patients with diabetic ketoacidosis and observed 261 deaths. The quartile cut-points for potassium concentration were 7.7, 11.4, and 16.1 mmol/L. Within the range of approximately 10 to 40 mmol/L, potassium concentration was not associated with occurrence of hyperkalemia or death. Lower potassium concentrations were associated with higher 28-day in-hospital mortality; the odds ratio for patients receiving 8 mmol/L was 1.69 (95% CI, 1.03 to 2.78; reference: 20 mmol/L), and the odds ratio increased monotonically as potassium concentration decreased further. CONCLUSION: Patients receiving potassium replacement at concentrations of 10 to 40 mmol/L had similar in-hospital mortality rates, whereas lower concentrations were associated with higher mortality.
引用
- Okada A, Yamana H, Morita K, et al. Potassium Concentration in Initial Fluid Therapy and In-Hospital Mortality of Patients with Diabetic Ketoacidosis. J Clin Endocrinol Metab. 2021. PMID: 33493293. doi:10.1210/clinem/dgab029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。